MacroGenics, Inc.
MGNX
$4.62
-$0.24-4.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.39% | 8.21% | -70.13% | 34.88% | 21.37% |
| Total Depreciation and Amortization | -4.74% | -16.95% | -2.51% | 5.30% | -3.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.28% | 108.42% | -43.90% | -31.18% | -5.19% |
| Change in Net Operating Assets | 85.53% | 1,921.30% | -1,170.33% | -662.40% | -8,106.71% |
| Cash from Operations | 23.63% | 212.01% | -150.17% | -5.62% | -2.73% |
| Capital Expenditure | 34.97% | 60.65% | 28.04% | 30.92% | 63.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 337.75% | -256.24% | -155.23% | -176.30% | -60.27% |
| Cash from Investing | 357.67% | -259.14% | -157.22% | -179.34% | -60.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -60.38% | -100.00% | -89.54% | -- |
| Repurchase of Common Stock | 22.70% | -50.00% | 100.00% | 100.00% | 88.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.60% | -63.23% | 100.00% | 11,058.24% | -213.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.95% | -812.66% | -152.83% | -516.10% | -80.91% |